These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 18475686

  • 1. A review of the tolerability and safety of levocabastine eye drops and nasal spray. Implications for patient management.
    Howarth PH.
    Mediators Inflamm; 1995; 4(7):S26-30. PubMed ID: 18475686
    [Abstract] [Full Text] [Related]

  • 2. Treatment of allergic rhinoconjunctivitis: a review of the role of topical levocabastine.
    Wijk RG.
    Mediators Inflamm; 1995; 4(7):S31-8. PubMed ID: 18475688
    [Abstract] [Full Text] [Related]

  • 3. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.
    Noble S, McTavish D.
    Drugs; 1995 Dec; 50(6):1032-49. PubMed ID: 8612470
    [Abstract] [Full Text] [Related]

  • 4. The pharmacokinetic properties of topical levocabastine. A review.
    Heykants J, Van Peer A, Van de Velde V, Snoeck E, Meuldermans W, Woestenborghs R.
    Clin Pharmacokinet; 1995 Oct; 29(4):221-30. PubMed ID: 8549024
    [Abstract] [Full Text] [Related]

  • 5. Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.
    Janssens MM.
    Rhinol Suppl; 1992 Sep; 13():39-49. PubMed ID: 1358140
    [Abstract] [Full Text] [Related]

  • 6. Levocabastine: an effective topical treatment of allergic rhinoconjunctivitis.
    Janssens MM, Vanden Bussche G.
    Clin Exp Allergy; 1991 May; 21 Suppl 2():29-36. PubMed ID: 1680536
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the efficacy and tolerability of topical levocabastine and sodium cromoglycate in the treatment of seasonal allergic rhinoconjunctivitis in children.
    Vermeulen J, Mercer M.
    Pediatr Allergy Immunol; 1994 Nov; 5(4):209-13. PubMed ID: 7894627
    [Abstract] [Full Text] [Related]

  • 8. Levocabastine nasal spray better than sodium cromoglycate and placebo in the topical treatment of seasonal allergic rhinitis.
    Schata M, Jorde W, Richarz-Barthauer U.
    J Allergy Clin Immunol; 1991 Apr; 87(4):873-8. PubMed ID: 1672878
    [Abstract] [Full Text] [Related]

  • 9. Faster onset of action with topical levocabastine than with oral cetirizine.
    Drouin MA, Yang WH, Horak F.
    Mediators Inflamm; 1995 Apr; 4(7):S5-S10. PubMed ID: 18475689
    [Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of topical levocabastine compared with oral terfenadine.
    Bahmer FA, Ruprecht KW.
    Ann Allergy; 1994 May; 72(5):429-34. PubMed ID: 7909999
    [Abstract] [Full Text] [Related]

  • 11. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis.
    Dechant KL, Goa KL.
    Drugs; 1991 Feb; 41(2):202-24. PubMed ID: 1709851
    [Abstract] [Full Text] [Related]

  • 12. Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis.
    Azevedo M, Castel-Branco MG, Oliveira JF, Ramos E, Delgado L, Almeida J.
    Clin Exp Allergy; 1991 Nov; 21(6):689-94. PubMed ID: 1685691
    [Abstract] [Full Text] [Related]

  • 13. Topical levocabastine, a selective H1 antagonist, in seasonal allergic rhinoconjunctivitis.
    Bende M, Pipkorn U.
    Allergy; 1987 Oct; 42(7):512-5. PubMed ID: 2891316
    [Abstract] [Full Text] [Related]

  • 14. Lack of effect of erythromycin and ketoconazole on the pharmacokinetics and pharmacodynamics of steady-state intranasal levocabastine.
    Pesco-Koplowitz L, Hassell A, Lee P, Zhou H, Hall N, Wiesinger B, Mechlinski W, Grover M, Hunt T, Smith R, Travers S.
    J Clin Pharmacol; 1999 Jan; 39(1):76-85. PubMed ID: 9987703
    [Abstract] [Full Text] [Related]

  • 15. Levocabastine eye drops are effective and well tolerated for the treatment of allergic conjunctivitis in children.
    Wüthrich B, Gerber M.
    Mediators Inflamm; 1995 Jan; 4(7):S16-20. PubMed ID: 18475684
    [Abstract] [Full Text] [Related]

  • 16. Topical levocabastine-a review of therapeutic efficacy compared with topical sodium cromoglycate and oral terfenadine on days with high pollen counts.
    Azevedo M.
    Mediators Inflamm; 1995 Jan; 4(7):S21-5. PubMed ID: 18475685
    [Abstract] [Full Text] [Related]

  • 17. Levocabastine eye drops do not affect accommodative capacity in volunteers and intraocular pressure in glaucoma patients.
    Wolf S, Wohlrab TM, Remky A.
    Eur J Ophthalmol; 1995 Jan; 5(4):225-9. PubMed ID: 8963158
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.